World's Best Scientists 2026 revealed!
Elizabeth A. Musgrove

Elizabeth A. Musgrove

D-Index & Metrics

Medicine

D-Index
83
Citations
38641
World Ranking
15379
National Ranking
1414

Overview

Elizabeth A. Musgrove is affiliated with the University of Glasgow in the United Kingdom. Their research primarily intersects the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Oncology and Molecular Biology subfields. Specific areas of investigation include Cancer Research and Epidemiology, as well as Periodontics.

The main topics covered by their work include:

  • Pancreatic and Hepatic Oncology Research
  • Epigenetics and DNA Methylation
  • Cancer Genomics and Diagnostics
  • Neuroendocrine Tumor Research Advances
  • Dental Health and Care Utilization
  • Geriatric Care and Nursing Homes
  • Nosocomial Infections in ICU

Elizabeth A. Musgrove has authored several recent papers, highlighting their engagement with pancreatic cancer and clinical care settings:

  • Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer, 2020, Gastroenterology
  • HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer, 2020, Cell Reports
  • Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence, 2021, Gastroenterology
  • Current oral care practices in an acute aged care setting: An Australian metropolitan hospital perspective, 2024, International Journal of Speech-Language Pathology

The publication venues where Elizabeth has frequently contributed include:

  • Gastroenterology
  • Cell Reports
  • International Journal of Speech-Language Pathology

Collaboration is notable in their work, with frequent co-authors comprising:

  • David K. Chang
  • Andrew V. Biankin
  • Nigel B. Jamieson
  • Rosanna Upstill-Goddard
  • Colin J. McKay

Best Publications

  • Genomic analyses identify molecular subtypes of pancreatic cancer

    Bailey P;Chang Dk;Nones K;Nones K;Johns Al

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Whole genomes redefine the mutational landscape of pancreatic cancer.

    Nicola Waddell;Marina Pajic;Ann Marie Patch;David K. Chang

  • Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

    D W Hedley;M L Friedlander;I W Taylor;C A Rugg

  • Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

    Andrew V. Biankin;Andrew V. Biankin;Andrew V. Biankin;Nicola Waddell;Karin S. Kassahn;Marie Claude Gingras

  • Biological determinants of endocrine resistance in breast cancer

    Elizabeth A. Musgrove;Robert L. Sutherland;Robert L. Sutherland

  • Cyclin D as a therapeutic target in cancer

    Elizabeth A. Musgrove;C. Elizabeth Caldon;Jane Barraclough;Andrew Stone

  • Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

    Vinod P. Balachandran;Marta Łuksza;Julia N. Zhao;Vladimir Makarov

  • Expression and amplification of cyclin genes in human breast cancer.

    M. F. Buckley;K. J. E. Sweeney;J. A. Hamilton;R. L. Sini

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Whole-genome landscape of pancreatic neuroendocrine tumours

    Aldo Scarpa;David K. Chang;Katia Nones;Katia Nones;Vincenzo Corbo

  • Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

    Owen W. J. Prall;Boris Sarcevic;Elizabeth A. Musgrove;Colin K. W. Watts

  • Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle

    Elizabeth A. Musgrove;Christine S. L. Lee;Michael F. Buckley;Robert L. Sutherland

  • Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.

    S F Doisneau-Sixou;C M Sergio;J S Carroll;R Hui

  • Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.

    E. A. Musgrove;J. A. Hamilton;C. S. L. Lee;K. J. E. Sweeney

  • PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality

    Elena Lopez-Knowles;Sandra A O'Toole;Catriona M McNeil;Catriona M McNeil;Ewan K. A Millar

  • Cyclins and breast cancer.

    Robert L. Sutherland;Elizabeth A. Musgrove

  • Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

    Christopher J. Ormandy;Elizabeth A. Musgrove;Rina Hui;Roger J. Daly

  • c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

    Owen W. J. Prall;Eileen M. Rogan;Elizabeth A. Musgrove;Colin K. W. Watts

  • The prognostic and predictive value of serum CA19.9 in pancreatic cancer

    Jeremy L Humphris;David K Chang;David K Chang;Amber L Johns;Christopher J Scarlett;Christopher J Scarlett

Frequent Co-Authors

Robert L. Sutherland
Robert L. Sutherland Garvan Institute of Medical Research
Andrew V. Biankin
Andrew V. Biankin University of Glasgow
James G. Kench
James G. Kench Royal Prince Alfred Hospital
Anthony J. Gill
Anthony J. Gill University of Sydney
Christopher J. Scarlett
Christopher J. Scarlett University of Newcastle Australia
Marina Pajic
Marina Pajic Garvan Institute of Medical Research
Roger J. Daly
Roger J. Daly Monash University
Alexander Swarbrick
Alexander Swarbrick Garvan Institute of Medical Research
Mark J. Cowley
Mark J. Cowley Garvan Institute of Medical Research
Sean M. Grimmond
Sean M. Grimmond University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in the medical field but looking for alternative or supportive career paths, there are several accessible options available online. Pursuing a nursing degree remains popular, and students can start their journey by applying to the easiest bsn program to get into, which can offer a streamlined admissions process.

Another flexible career option is in medical administration and records. Many professionals find success through medical billing and coding schools online with financial aid, which provide important skills for managing patient data and navigating healthcare systems.

For students concerned about entrance exams, exploring nursing schools that don't require teas test can simplify the admissions process and help them get started sooner.

Finally, those interested in leadership roles within healthcare may want to consider earning a healthcare administration degree online. This pathway is ideal for individuals looking to move into management or administrative positions within medical settings.

Best Scientists Citing Elizabeth A. Musgrove

Trending Scientists

Recently Published Articles